Edwards Lifesciences EW announced that the FDA approved its SAPIEN M3 transcatheter mitral valve replacement system, making ...

All In Solutions Detox, a CARF-accredited addiction treatment center, highlights the critical role that comfort and compassionate care play in successful detoxification and recovery outcomes. The ...

Edwards Lifesciences has claimed an FDA approval for its Sapien M3 transcatheter mitral valve replacement system—marking the ...

All In Solutions Detox CA LLC has announced the implementation of enhanced clinical protocols designed to improve patient ...

We have only just started to understand how our brains clean themselves, but columnist Helen Thomson finds promising evidence ...

Now, MDLifespan, the nation’s first physician-led brand dedicated exclusively to toxin removal and regenerative wellness, has expanded to Florida with a new PlasmaXchange™ location in partnership with ...

After a free, evidence-based guide to health and wellness? Sign up to our weekly Well Informed newsletter. NO SOCIAL MEDIA. No gambling, alcohol or junk food. Certainly no masturbation, pornography or ...

SAN FRANCISCO -- For selected patients with mitral regurgitation (MR), the Sapien M3 device delivered highly promising 1-year outcomes for the desperate field of transcatheter mitral valve replacement ...

Edwards Lifesciences (NYSE: EW) today announced seven-year data from the PARTNER 3 trial, reaffirming the early and sustained patient benefits of Edwards TAVR. The data, which showed superior clinical ...

SAN FRANCISCO, October 27, 2025--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced seven-year data from the PARTNER 3 trial, reaffirming the early and sustained patient benefits of ...

SAN FRANCISCO, CA—Transcatheter mitral valve replacement (TMVR) with the novel Sapien M3 device (Edwards Lifesciences) is associated with low rates of adverse clinical outcomes and sustained ...